Zoom's shares closed up 11.28% after analysts at Baird estimated that Zoom's 2023 investment in Anthropic could be worth $2B to $4B, depending on dilution
Context & Ripple Effects
Zoom had been relying on modest core-business growth and a $1.5B buyback to support its equity story after its 2024 quarterly results showed limited revenue growth. Baird's estimate reframes the Anthropic holding as a potentially material asset alongside that operating business.
The estimate is explicitly sensitive to dilution, so it is a valuation lens rather than a realized gain. Later filing-based coverage similarly put a concrete value on Zoom's Anthropic stake, underscoring why investors are tracking the holding separately from Zoom's collaboration products.
First-order effects
- Zoom shareholders immediately gained a new basis for valuing the company: Baird estimated its 2023 Anthropic investment at $2B-$4B, helping drive the reported 11.28% share-price move.
- The market now has a clearer reason to separate the value of Zoom's operating performance from the prospective value of its Anthropic stake; the range remains contingent on future dilution.
Second-order effects
- Zoom's valuation may become more sensitive to Anthropic financing and ownership changes, making disclosures about the stake more consequential for investors than they were when it was simply a strategic investment.
- Other mature software companies with AI investments may face greater pressure to explain whether those stakes are strategic product bets, financial assets, or both.
Third-order effects
- If private AI-company valuations remain influential, public software companies that invested early could increasingly be assessed through a sum-of-the-parts framework rather than solely on subscription-growth metrics.
- That dynamic can make dilution, liquidity and valuation methodology central risks: paper gains can improve market perception without translating into cash or operating growth.
The trend: Corporate AI partnerships are increasingly creating balance-sheet exposure that can reshape how public software companies are valued.